BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36253320)

  • 21. Abdominoperineal resection for rectal cancer at a specialty center.
    Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
    Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
    Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach.
    Fleischmann M; Diefenhardt M; Trommel M; Scherf C; Ramm U; Chatzikonstantinou G; Fokas E; Rödel C; Tselis N
    Strahlenther Onkol; 2022 Jul; 198(7):654-662. PubMed ID: 35445815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of the rectum is possible in early rectal cancer with neoadjuvant radiotherapy, delay and local excision-a 12-year single-centre experience of the evolution of early rectal cancer treatment.
    Bilkhu A; Robinson JM; Steward MA
    Colorectal Dis; 2021 Jul; 23(7):1765-1776. PubMed ID: 33724612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
    Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
    Sun Myint A; Smith FM; Gollins SW; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman MJ; Fekete Z; Perkins K; Pritchard DM
    Br J Radiol; 2017 Dec; 90(1080):20170175. PubMed ID: 28937269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of radiotherapy in the treatment of rectal cancer in older patients.
    Myint AS; Gérard JP
    Eur J Surg Oncol; 2020 Mar; 46(3):349-357. PubMed ID: 31926607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.
    Garlipp B; Ptok H; Schmidt U; Meyer F; Gastinger I; Lippert H
    Langenbecks Arch Surg; 2010 Nov; 395(8):1031-8. PubMed ID: 20711786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends and Variation in the Use of Radiotherapy in Non-metastatic Rectal Cancer: a 14-year Nationwide Overview from the Netherlands.
    Verrijssen AE; Evers J; van der Sangen M; Siesling S; Aarts MJ; Struikmans H; Bloemers MCWM; Burger JWA; Lemmens V; Braam PM; Elferink MAG; Berbee M
    Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):221-232. PubMed ID: 38336504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical predictors of response to chemoradiotherapy for rectal cancer as an aid to organ preservation.
    Fischer J; Eglinton TW; Frizelle FA
    ANZ J Surg; 2021 Jun; 91(6):1190-1195. PubMed ID: 33404195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
    Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local tumor regrowth after clinical complete response following neoadjuvant therapy for rectal cancer: what happens when organ preservation falls short.
    Cerdán-Santacruz C; Vailati BB; São Julião GP; Habr-Gama A; Perez RO
    Tech Coloproctol; 2023 Jan; 27(1):1-9. PubMed ID: 35986804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives.
    Fokas E; Glynne-Jones R; Fleischmann M; Piso P; Tselis N; Ghadimi M; Hofheinz RD; Rödel C
    Cancer Treat Rev; 2023 Jan; 112():102490. PubMed ID: 36463667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Cost-effectiveness of Watch and Wait for Rectal Cancer.
    Bibi S; Edilbe MW; Rao C
    Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):132-137. PubMed ID: 36266161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rectal cancer: Towards personalized medicine].
    Vendrely V; Benoist S
    Cancer Radiother; 2021 Oct; 25(6-7):650-654. PubMed ID: 34266737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Rectal Cancer Without Radical Resection.
    Beets GL; Figueiredo NF; Beets-Tan RG
    Annu Rev Med; 2017 Jan; 68():169-182. PubMed ID: 27618750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
    Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
    Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
    São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
    Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.